CN100510098C - 旋光芳香杂环β-羟基酯、由β-酮基酯制备其的方法以及这些β-酮基酯的制备方法 - Google Patents

旋光芳香杂环β-羟基酯、由β-酮基酯制备其的方法以及这些β-酮基酯的制备方法 Download PDF

Info

Publication number
CN100510098C
CN100510098C CNB2004800395725A CN200480039572A CN100510098C CN 100510098 C CN100510098 C CN 100510098C CN B2004800395725 A CNB2004800395725 A CN B2004800395725A CN 200480039572 A CN200480039572 A CN 200480039572A CN 100510098 C CN100510098 C CN 100510098C
Authority
CN
China
Prior art keywords
compound
saccharomyces
pichia
yeast
candida
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2004800395725A
Other languages
English (en)
Chinese (zh)
Other versions
CN1902322A (zh
Inventor
约翰内斯·普拉策克
路德维希·措恩
贝恩德·布赫曼
维尔纳·斯库巴拉
奥尔林·彼得罗夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of CN1902322A publication Critical patent/CN1902322A/zh
Application granted granted Critical
Publication of CN100510098C publication Critical patent/CN100510098C/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CNB2004800395725A 2003-12-31 2004-12-21 旋光芳香杂环β-羟基酯、由β-酮基酯制备其的方法以及这些β-酮基酯的制备方法 Expired - Fee Related CN100510098C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10361794A DE10361794B3 (de) 2003-12-31 2003-12-31 Optisch aktive heteroaromatische ß-Hydroxy-Ester und Verfahren zu deren Herstellung sowie deren Verwendung als Zwischenprodukte bei der Epothilon-Totalsynthese
DE10361794.9 2003-12-31

Publications (2)

Publication Number Publication Date
CN1902322A CN1902322A (zh) 2007-01-24
CN100510098C true CN100510098C (zh) 2009-07-08

Family

ID=34716267

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004800395725A Expired - Fee Related CN100510098C (zh) 2003-12-31 2004-12-21 旋光芳香杂环β-羟基酯、由β-酮基酯制备其的方法以及这些β-酮基酯的制备方法

Country Status (17)

Country Link
EP (1) EP2113031A1 (de)
JP (1) JP2007516999A (de)
KR (1) KR20070029641A (de)
CN (1) CN100510098C (de)
AU (1) AU2004309076A1 (de)
BR (1) BRPI0418254A (de)
CA (1) CA2546981A1 (de)
CR (1) CR8492A (de)
DE (1) DE10361794B3 (de)
EC (1) ECSP066740A (de)
HK (1) HK1097000A1 (de)
IL (1) IL175908A0 (de)
MX (1) MXPA06007564A (de)
NO (1) NO20063477L (de)
RU (1) RU2006127553A (de)
WO (1) WO2005064006A1 (de)
ZA (1) ZA200606293B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104328152A (zh) * 2014-10-13 2015-02-04 青岛科技大学 一种产朊酵母催化生产亚环己基烯醇的方法
CN108118004B (zh) * 2017-12-15 2021-06-25 北京工商大学 一株喜仙人掌毕赤酵母在水果采后病害防治中的应用
CN110283733B (zh) * 2019-06-20 2020-10-27 浙江工业大学 土星轮头酵母zjph1807及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7257096A (en) * 1995-10-04 1997-04-28 Fmc Corporation Herbicidal 6-heterocyclic indazole derivatives
US5942644A (en) * 1997-05-27 1999-08-24 Biocatalytics, Inc. Precursors for the production of chiral vicinal aminoalcohols
US6211412B1 (en) * 1999-03-29 2001-04-03 The University Of Kansas Synthesis of epothilones
PE20010116A1 (es) * 1999-04-30 2001-02-15 Schering Ag Derivados de 6-alquenil-, 6-alquinil- y 6-epoxi-epotilona, procedimientos para su preparacion
JP2001213874A (ja) * 1999-07-22 2001-08-07 Mercian Corp イソクマリン誘導体の製造およびそのための中間体
DE10041470A1 (de) * 2000-08-18 2002-02-28 Schering Ag 12,13-Cyclopropyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
WO2003029195A1 (fr) * 2001-09-28 2003-04-10 Sumika Fine Chemicals Co., Ltd. Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production
JP4432315B2 (ja) * 2002-03-19 2010-03-17 三菱化学株式会社 光学活性３−ヒドロキシ−３−（２’−チエニル）プロピオン酸エステル誘導体の製造方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Enantioselective Hydrogenation of -Keto Esters using ChiralDiphosphine-Ruthenium Complexes: Optimization forAcademic and Industrial Purposes and SyntheticApplications. RATOVELOMANANA-VIDAL ET AL.ADVANCED SYNTHESIS & CATALYSIS,Vol.345 No.1/2. 2003 *
DE 100 41 470 A1 2002.02.28 *

Also Published As

Publication number Publication date
HK1097000A1 (en) 2007-06-15
JP2007516999A (ja) 2007-06-28
CN1902322A (zh) 2007-01-24
ECSP066740A (es) 2006-10-31
RU2006127553A (ru) 2008-02-10
MXPA06007564A (es) 2006-12-14
ZA200606293B (en) 2009-08-26
DE10361794B3 (de) 2005-10-06
IL175908A0 (en) 2006-10-05
BRPI0418254A (pt) 2007-04-17
AU2004309076A1 (en) 2005-07-14
NO20063477L (no) 2006-08-23
CA2546981A1 (en) 2005-07-14
WO2005064006A1 (en) 2005-07-14
EP2113031A1 (de) 2009-11-04
CR8492A (es) 2007-03-08
KR20070029641A (ko) 2007-03-14

Similar Documents

Publication Publication Date Title
US10538507B2 (en) Preparation process for high-purity dabigatran etexilate
CN100510098C (zh) 旋光芳香杂环β-羟基酯、由β-酮基酯制备其的方法以及这些β-酮基酯的制备方法
CN105473552B (zh) 用于产生吡咯衍生物及其中间体的方法
WO2013190455A2 (en) Process for the preparation of lurasidone hydrochloride
CN104529895A (zh) 一种含氮杂环化合物的合成方法
CN104402793A (zh) 一种3-取代氧化吲哚衍生物及其合成方法和应用
CN107602559B (zh) 一种通过迈克尔加成引发的不对称环丙化合成手性三元碳环核苷的方法
CN1313766A (zh) 新的切割dna的抗肿瘤剂
CN1009826B (zh) 制备喹啉基化合物的方法
US7935827B2 (en) Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters
CN107162951B (zh) 一种靛红-3-肟衍生物的制备方法
CN106854177B (zh) 一种6-氯-4-羟基吡啶-3-甲醛的制备方法
CN108558745A (zh) 一种帕博西林中间体的合成方法
CN104649865B (zh) (r)-苯基乙二醇的一种绿色不对称合成方法
CN103193770A (zh) 取代苯并噻唑类抗真菌化合物及其制备方法与应用
CN100494199C (zh) 烟曲霉震颤素c类似物、其合成方法及其用途
CN104098524B (zh) 1-间甲氧基苯甲酰基-3-苯基-1,4-二氢-1,2,4,5-四嗪及制备和应用
CN109942584B (zh) 一种Beclabuvir中间体的合成方法
CN105061430A (zh) 一种抗肿瘤化合物的制备方法和用途
CN104557665A (zh) 光学活性3-取代吲哚衍生物及其合成方法和应用
CN104788443B (zh) 一种利伐沙班关键中间体的合成制备方法
CN108003150A (zh) 4-杂芳基喹啉酮衍生物的制备方法及其应用
CN102212030A (zh) 取代四氢咔唑类抗真菌化合物及其制备方法
CN114249724B (zh) 一种唑吡坦中间体的制备方法
CN107383076A (zh) 一种3‑氨基‑4‑氯苯基硼酸频哪醇酯的合成方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1097000

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1097000

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090708

Termination date: 20111221